HEXABODY Trademark

Trademark Overview


On Thursday, November 15, 2012, a trademark application was filed for HEXABODY with the United States Patent and Trademark Office. The USPTO has given the HEXABODY trademark a serial number of 79124376. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Tuesday, November 24, 2020. This trademark is owned by Genmab A/S. The HEXABODY trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, bi and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases

Legal services in the form of patent exploitation, namely, patent consultation, patent licensing, and providing information about patent rights; licensing of intellectual property in the field of medicine

Chemical, biochemical, biological, and biotechnological, preparations, namely, antibodies, bi- and multispecific antibodies as well as fragments, monovalent antibodies, derivatives of conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases

Medical, scientific and biological research; [ medical, scientific and biological ] research in [ the field of ] antibodies, bi and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies, bi and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these; chemical analysis [ ; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy; development of pharmaceuticals containing antibodies, bi and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these ]
hexabody

General Information


Serial Number79124376
Word MarkHEXABODY
Filing DateThursday, November 15, 2012
Status706 - SECTION 71 ACCEPTED
Status DateTuesday, November 24, 2020
Registration Number4496618
Registration DateTuesday, March 18, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2013

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, bi and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases
Pseudo MarkHEXA BODY
Goods and ServicesLegal services in the form of patent exploitation, namely, patent consultation, patent licensing, and providing information about patent rights; licensing of intellectual property in the field of medicine
Goods and ServicesChemical, biochemical, biological, and biotechnological, preparations, namely, antibodies, bi- and multispecific antibodies as well as fragments, monovalent antibodies, derivatives of conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases
Goods and ServicesMedical, scientific and biological research; [ medical, scientific and biological ] research in [ the field of ] antibodies, bi and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies, bi and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these; chemical analysis [ ; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy; development of pharmaceuticals containing antibodies, bi and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these ]

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, February 4, 2013
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 4, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 4, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 4, 2013
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenmab B.V.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressUtrecht NL-3584C
NL

Party NameGenmab B.V.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNL

Party NameGenmab B.V.
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressNL

Party NameGenmab A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK

Trademark Events


Event DateEvent Description
Tuesday, March 12, 2013ASSIGNED TO EXAMINER
Thursday, January 31, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, February 4, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 8, 2013APPLICATION FILING RECEIPT MAILED
Tuesday, March 19, 2013NON-FINAL ACTION WRITTEN
Wednesday, March 20, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, March 20, 2013REFUSAL PROCESSED BY MPU
Wednesday, March 20, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 19, 2013CHANGE OF OWNER RECEIVED FROM IB
Monday, May 6, 2013REFUSAL PROCESSED BY IB
Friday, September 20, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 20, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 20, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 18, 2013EXAMINERS AMENDMENT -WRITTEN
Friday, October 18, 2013EXAMINERS AMENDMENT E-MAILED
Friday, October 18, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 18, 2013EXAMINER'S AMENDMENT ENTERED
Friday, November 1, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 22, 2013ASSIGNED TO LIE
Friday, November 22, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 11, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 11, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 11, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, December 30, 2013NOTIFICATION PROCESSED BY IB
Tuesday, December 31, 2013PUBLISHED FOR OPPOSITION
Friday, June 20, 2014FINAL DISPOSITION PROCESSED
Tuesday, December 31, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 18, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, June 18, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, June 20, 2014FINAL DISPOSITION NOTICE SENT TO IB
Saturday, July 12, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 9, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, April 20, 2017NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, March 17, 2020TEAS SECTION 71 RECEIVED
Friday, September 8, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, June 14, 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, March 18, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, April 30, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 1, 2020POST REGISTRATION ACTION MAILED - SEC.71
Tuesday, November 24, 2020NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Monday, November 2, 2020TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, November 24, 2020REGISTERED-SEC.71 ACCEPTED
Saturday, March 18, 2023COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Saturday, July 24, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, August 3, 2021INVALIDATION PROCESSED
Tuesday, August 3, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, September 25, 2021PARTIAL INVALIDATION PROCESSED BY THE IB
Friday, December 2, 2022INTERNATIONAL REGISTRATION RENEWED
Wednesday, June 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 5, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 5, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Monday, September 16, 2024TEAS SECTION 71 RECEIVED